Showing results (311-320 of 556) with videos related to
Sort By:
Pageof 56
Nuclear Medicine Communications|March 11, 1992
Focus localization in patients with partial epilepsy with 99Tcm-HMPAO SPECT under continuous surface EEG monitoringN P Verhoeff, H C Weinstein, A P Aldenkamp, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 1, 1996
Oregon's Medicaid ranking and cost-effectiveness: is there any relationship?T O Tengs, G Meyer, J E Siegel, et al.Vaccines|April 23, 2022
An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United KingdomMichael Maschio, Michele A Kohli, Mansoor Ashraf, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|March 26, 2015
Limited Efficacy of a Long-term Secondary Prevention Program in Ischemic Stroke and Transient Ischemic Attack PatientsSander M Van Schaik, Renske M Van den Berg-Vos, Henry C Weinstein, et al.Pharmacoeconomics|October 13, 2010
Methods of model calibration: observations from a mathematical model of cervical cancerDouglas C A Taylor, Vivek Pawar, Denise Kruzikas, et al.Cancer|February 1, 2007
Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USSamuel Aballéa, Jeremy V M Chancellor, Maria Raikou, et al.Acta Ophthalmologica|April 11, 2016
Aflibercept vs. Ranibizumab: cost-effectiveness of treatment for wet age-related macular degeneration in SwedenHemangi R Panchmatia, Karen M Clements, Erin Hulbert, et al.BMC Musculoskeletal Disorders|April 11, 2019
Inflammatory biomarkers in patients with sciatica: a systematic reviewMaarten J Jungen, Bastiaan C Ter Meulen, Tim van Osch, et al.Pharmacoeconomics|January 7, 1997
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and MedicineJ E Siegel, G W Torrance, L B Russell, et al.BMC Infectious Diseases|January 23, 2010
Public health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) in the context of the annual influenza epidemic and a severe influenza pandemicJaime L Rubin, Lisa J McGarry, Keith P Klugman, et al.Pageof 56